Related Experiment Video
Updated: Jun 9, 2026

Ultrasonographic Evaluation of Salivary Glands for Sjogren's Syndrome: Diagnostic and Monitoring Insights
Published on: October 13, 2023
Factor analysis of the clinical characteristics of primary Sjogren syndrome
Barbara Caffery1, Trefford Simpson, Sunny Wang
1School of Optometry, University of Waterloo, Waterloo, Ontario, Canada. barbaracafferyeyes@yahoo.ca
Purpose:
The purpose of this study was to use factor analysis to analyze 90 clinical characteristics of a cohort of 231 patients with primary Sjogren syndrome (pSS).
Methods:
The records of all patients seen at the University Health Network Sjogren Syndrome Clinic from October 1992 to July 2006 were reviewed and documented. Those diagnosed as pSS by the American European Consensus Criteria of 2002 were included. The 90 clinical variables, including health history, blood analysis, symptoms of dry eye and dry mouth, salivary flow and biopsy, tear flow and staining, were analyzed by factor analysis.
Results:
Two hundred thirty-one patients with pSS charts were reviewed, and 90 variables were recorded. Factor analysis resulted in three factors: factor 1: ocular surface staining, factor 2: antimicrosomal antibodies and antithyroid antibodies, and factor 3: serum anti-Ro and anti-La.
Conclusions:
Ocular surface staining accounted for the greatest variance in this population of patients with pSS.
Related Concept Videos
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
Factors Affecting Illness
For instance, risk factors are connected to illness, disability,...
Inflammatory Bowel Disease IV: Clinical Manifestations
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Autoimmune Disorders
Concept and Mechanism of Autoimmune Diseases
The immune system...
